Loading this company
CSL Limited
CSL.AXPrices in AUD
TickerWorth ScoreF37/100
What we think
Priced above our range of A$61.06 to A$176.08.
Price
A$194.05AUD up +A$7.15 (+3.83%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 15:46 UTC (4 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 4 models, on today’s numbers
A$61.06–A$176.08
What the price needs: revenue growth of 15.9%/yr for 5 years (our model assumes 4.7%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price A$194.05Priced · Prices are delayed.
Is it a good business?
- Valuation25 out of 100
- Growth50 out of 100
- Financial health67 out of 100
- Dividend100 out of 100
- Past performance0 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
A$185.31 across 17 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. It operates in the Biotechnology industry (Healthcare sector), headquartered in Australia. The company employs roughly 29,000 people.
Key stats
52-week rangeA$90.00–A$221.76
- Open
- A$188.49
- Day high
- A$192.58
- Day low
- A$187.32
- Previous close
- A$186.90
- Volume
- 1,615,197 · 1.26× avg
- Average volume
- 1,277,329
- Market cap
- A$92,233,760,768.00
- P/E (TTM)
- —
- Earnings per share
- −A$7.90
- Beta
- 0.08
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
No filings or corporate activity on file in the recent window.
Top news
No recent headlines we can cite for this company.
Insider trades
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.